ライフサイエンスコーパス: respiratory infection

1 age or a less severe syndrome, such as upper respiratory infection).

2 ontrol IAV replication and succumb to lethal respiratory infection.

3 pes and organ systems dictate the outcome of respiratory infection.

4 erate or severe exacerbation and first upper respiratory infection.

5 tinopathy, migraine disorder, and post-upper respiratory infection.

6 a portal of entry for the establishment of a respiratory infection.

7 t important challenge to understanding lower respiratory infection.

8 8(+) Trm cells in the lung airways following respiratory infection.

9 rsening disease outcome is a new paradigm in respiratory infection.

10 lung tissue of alpaca that died of a severe respiratory infection.

11 e immune response during Pseudomonas-induced respiratory infection.

12 r antiviral treatment of patients with viral respiratory infection.

13 essential role in both persistence and acute respiratory infection.

14 opulations that are generated in response to respiratory infection.

15 er respiratory tract, increasing the risk of respiratory infection.

16 thology following intranasal inoculation and respiratory infection.

17 naling axis they activate to protect against respiratory infection.

18 urine host's gene expression and response to respiratory infection.

19 CD11b(+) macrophages in the lungs following respiratory infection.

20 aryngeal niche, a reservoir for ME and upper respiratory infections.

21 tant feature of diabetes that predisposes to respiratory infections.

22 ng antibiotic therapy in patients with acute respiratory infections.

23 uals and may help reduce symptoms related to respiratory infections.

24 us (RSV) is associated with severe childhood respiratory infections.

25 erate or severe COPD exacerbations and upper respiratory infections.

26 ial to revolutionize vaccine development for respiratory infections.

27 sorders, increased susceptibly to cancer and respiratory infections.

28 host protective against bacterial and viral respiratory infections.

29 associated with susceptibility to asthma and respiratory infections.

30 of asthma exacerbations are related to viral respiratory infections.

31 set inflammatory bowel disease and recurrent respiratory infections.

32 anisms and are therefore equipped to control respiratory infections.

33 ndings for early diagnosis and prevention of respiratory infections.

34 s in families remain a valuable way to study respiratory infections.

35 have a significant impact on the outcome of respiratory infections.

36 ly to the battle against influenza and other respiratory infections.

37 ir pollution exposure and the development of respiratory infections.

38 uary 2011 from patients with suspected acute respiratory infections.

39 fluid specimens from subjects with suspected respiratory infections.

40 n reduced the incidence of diarrhea or lower respiratory infections.

41 responses as a therapeutic modality to treat respiratory infections.

42 sed guidelines can reduce antibiotic use for respiratory infections.

43 l of individuals with high susceptibility to respiratory infections.

44 entification of these causative pathogens in respiratory infections.

45 Disruption of ciliary flow can lead to respiratory infections.

46 monologist views the conceptual framework of respiratory infections.

47 phages are the first line of defense against respiratory infections.

48 B) may confer nonspecific protection against respiratory infections.

49 CI 0.60-1.24, p=0.42) or time to first upper respiratory infection (0.95, 0.69-1.31, p=0.75).

50 ng ever-smokers associated with infant lower respiratory infection (-108.2 ml; P = 0.001) and home ov

51 sh (23/3), decreased appetite (20/15), upper respiratory infection (20/0), pneumonia (13/10), and ala

52 mission diagnoses of patients with AIDS were respiratory infection (28.6%) and sepsis (16.9%), which

53 Of 6001 medically attended respiratory infections, 302 (5%) were caused by RSV.

54 by cerebrovascular disease (7.5%) and lower respiratory infections (4.9%).

55 had multiple diagnoses), 62.2% had an acute respiratory infection; 5.0% of these infections were rad

56 Among 1,293 children with respiratory infections, 797(61.6%) were infected with RS

57 iated with increased susceptibility to upper respiratory infection-a major precipitant of exacerbatio

58 Respiratory infections account for a large percentage of

59 escribe the molecular epidemiology of HAdV21 respiratory infections across the country, 150 clinical

60 iddle East respiratory syndrome severe acute respiratory infection (adjusted odds ratio, 5.87; 95% CI

61 ction (admission HRR, 0 [95% CI, 0-.24]) and respiratory infections (admission HRR, 0.37 [95% CI, .16

62 jection, lymphocytic bronchiolitis (LB), and respiratory infection after lung transplantation (LTx).

63 not with acute or chronic rejection, LB, and respiratory infections after LTx.

64 h many health effects, including acute lower respiratory infection (ALRI) in young children.

65 The timing of a child's first acute lower respiratory infection (ALRI) is important, because the y

66 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199

67 in-hospital deaths due to severe acute lower respiratory infections (ALRI) in young children worldwid

68 h chronic rejection, LB, acute rejection, or respiratory infections, although significantly less pati

69 species, are the causative agents of severe respiratory infections among children and are linked to

70 effect of facemasks and respirators against respiratory infections among healthcare workers.

71 ry syncytial virus (RSV) is a major cause of respiratory infections among young children and can lead

72 ate genes and 10 phenotypes related to viral respiratory infection and asthma control were examined i

73 RSV is the most common cause of acute lower respiratory infection and bronchiolitis.

74 risk for experimentally induced acute upper respiratory infection and clinical illness.

75 ignificant morbidity and mortality are acute respiratory infection and dehydration from severe diarrh

76 In addition, the acute respiratory infection and diarrheal illness burden and t

77 Overt respiratory infection and immunosuppression carry a high

78 hR) correlates with poorer ability to combat respiratory infection and lower antibody levels in the o

79 with reduced time in the hospital with acute respiratory infection and reduced diastolic blood pressu

80 Cough is a predominant feature of respiratory infection and, in tuberculosis, is of prime

81 The early phenotype was more likely to have respiratory infections and acute exacerbations at baseli

82 suggests associations with increased risk of respiratory infections and all-cause mortality.

83 agnoses despite hypotheses relating ozone to respiratory infections and allergic responses.

84 t can cause a multitude of diseases, such as respiratory infections and conjunctivitis.

85 ity characterized by chronic upper and lower respiratory infections and defects in laterality.

86 eutrophil migratory accuracy with age during respiratory infections and determine if and how a statin

87 Respiratory infections and diseases are among the leadin

88 pah virus emerged a few years later, causing respiratory infections and encephalitis in Southeast Asi

89 raw cow's milk reduced the risk of manifest respiratory infections and fever by about 30%.

90 Infants suffer disproportionately from respiratory infections and generate reduced vaccine resp

91 Human bocavirus 1 (HBoV1) causes severe respiratory infections and HBoV2 to HBoV4 cause gastroin

92 dyskinesia (PCD), characterized by recurrent respiratory infections and male infertility.

93 lated inflammasome activation contributes to respiratory infections and pathologic airway inflammatio

94 is a potential therapeutic target for upper respiratory infections and that flavones may have clinic

95 er, excessive mucus contributes to transient respiratory infections and to the pathogenesis of numero

96 ovide insight into the pathogenesis of viral respiratory infections and virus-induced exacerbations o

97 to the protective effect of breastfeeding on respiratory infections and wheezing in early infancy.

98 t common adverse events were headache, upper respiratory infection, and fatigue.

99 ion related to autoimmune diseases, smoking, respiratory infection, and pollution exposure, and possi

100 separately, duration of gastrointestinal and respiratory infections, and duration of hospitalization)

101 were collected during maternal acute febrile respiratory infections, and from infants with any respir

102 ur in chronic obstructive pulmonary disease, respiratory infections, and neutrophilic asthma.

103 [95% confidence interval {CI}, .76-.95]) and respiratory infection (aOR, 0.82 [95% CI, .75-.90]) and

104 In a subgroup of sufferers, respiratory infections are associated with the developme

105 Upper and lower respiratory infections are common in early childhood and

106 As respiratory infections are common in human neonates and

107 Acute respiratory infections are responsible for more than 4 m

108 Diarrhoea and respiratory infections are the two biggest causes of chi

109 Viral respiratory infections are usually mild and self-limitin

110 Surveillance for acute respiratory infection (ARI) and influenza-like illness (

111 Previous studies have suggested that acute respiratory infection (ARI) and nonsteroidal anti-inflam

112 We find that malaria, acute respiratory infection (ARI), and diarrhea incidence are

113 viral pathogens, causing epidemics of acute respiratory infection (ARI), especially bronchiolitis an

114 ce Project (IISP) monitored outpatient acute respiratory infection (ARI; defined as the presence of >

115 iratory visits, including specifically acute respiratory infections (ARI), asthma, pneumonia, chronic

116 tection and management of outbreaks of acute respiratory infections (ARI), including influenza.

117 s to reduce antibiotic prescribing for acute respiratory infections (ARIs), information on factors th

118 reservoir for microbes associated with acute respiratory infections (ARIs).

119 clinical trials, using an established mouse respiratory infection as a model and starting treatment

120 We investigated early-life respiratory infections as predictors of the development

121 BALT) is associated with immune responses to respiratory infections as well as with local pathology d

122 n inherited disease characterised by chronic respiratory infections associated with bronchiectasis.

123 Both upper and lower respiratory infections at 12 months also increased the l

124 s of day care attendance and number of lower respiratory infections at 12 months were associated with

125 ve hours of day care attendance and reported respiratory infections at ages 1-4.

126 unced associations were seen for acute upper respiratory infections at multiple and unspecified sites

127 ing treatment for asthma, and without recent respiratory infections (baseline COPD was not an exclusi

128 chronic obstructive pulmonary disease, lower respiratory infections, breast cancer, other cardiovascu

129 ibutes to TCD8 impairment during viral lower respiratory infection, but how it regulates TCD8 impairm

130 1%) samples submitted for viral diagnosis of respiratory infection, but not in normal adult control s

131 The microbiota promotes resistance to respiratory infection, but the mechanistic basis for thi

132 tibody protects against RSV-associated lower respiratory infections, but placental malaria (PM) and m

133 oap could substantially reduce diarrhoea and respiratory infections, but prevalence of adequate handw

134 ed the importance of the Bvg(+) phase during respiratory infection, Bvg-regulated gene activation in

135 (CD8)) are impaired during acute viral lower respiratory infection by the inhibitory receptor program

136 mbers of the microbiota that protect against respiratory infection by the major human pathogens Strep

137 Viral respiratory infections can cause acute wheezing illnesse

138 January 2014; 50 of them died of the severe respiratory infection caused by these viruses.

139 Pediatric respiratory infections caused by antibiotic-nonsusceptib

140 Thus we hypothesized that respiratory infections causes the release of EVs in the

141 causative agent of whooping cough, a serious respiratory infection causing hundreds of thousands of d

142 Respiratory infections (comprising both upper and lower

143 Lower respiratory infections contributed to the highest propor

144 n particular smokers are more susceptible to respiratory infections contributing to acute exacerbatio

145 to be due to a cold, otitis media, an upper respiratory infection, croup, asthma, bronchitis, bronch

146 The risk of SSTI and respiratory infection decreased after bariatric surgery

147 icas in the mid-1990s as the cause of severe respiratory infections, designated hantavirus pulmonary

148 For many bacterial respiratory infections, development of (severe) disease

149 iciency is closely associated with stunting, respiratory infections, diarrhea, and dermatitis.

150 of 135 previously healthy infants with acute respiratory infection due to human rhinovirus (HRV; n =

151 ese features with patients with severe acute respiratory infection due to other etiologies.

152 lesser extent, among children who had had a respiratory infection during the first year of life (haz

153 oantibody seroconversion was associated with respiratory infections during the first 6 months of life

154 alth-care workers (HCWs) during outbreaks of respiratory infections (e.g. Influenza A H1N1 (2009)) is

155 y ventilated patients with severe sepsis and respiratory infection, early treatment with a neuromuscu

156 valid exposure route for a potentially fatal respiratory infection, even for viruses that do not demo

157 that acute otitis media occurs during upper respiratory infection, even in the absence of nasopharyn

158 Mouse respiratory infection experiments determined that catech

159 the most common adverse event of grade 2 was respiratory infection (five patients).

160 XDR-Ab causes VAP and other respiratory infections following SOT that are associated

161 ischaemic heart disease for males and lower respiratory infection for females.

162 iddle East respiratory syndrome severe acute respiratory infection from other etiologies; therefore,

163 of critically ill patients with severe acute respiratory infection from the Middle East respiratory s

164 onin-guided treatment in patients with acute respiratory infections from different clinical settings.

165 ve pulmonary disease, lung cancer, and lower respiratory infections from epidemiological studies usin

166 iddle East respiratory syndrome severe acute respiratory infection had more severe hypoxemic respirat

167 -infected participants in the HAART era with respiratory infections had an increased risk of death co

168 roportion to global estimates of acute lower respiratory infection hospitalizations among children ag

169 n lead to adverse health outcomes, including respiratory infections, impaired lung function, cardiac

170 nasal swabs as potential biomarkers of viral respiratory infection in children.

171 Respiratory infection in cystic fibrosis (CF) is polymic

172 occus equi subspecies equi that causes upper respiratory infection in horses.

173 RSV) is the most common cause of acute lower respiratory infection in infants and young children and

174 virus (RSV) is a major cause of severe lower respiratory infection in infants and young children and

175 revalent, parvovirus that is associated with respiratory infection in infants and young children.

176 eumovirus (HMPV) is a leading cause of acute respiratory infection in infants, children, and the elde

177 NALE: Bronchiolitis is the most common lower respiratory infection in infants; however, it remains un

178 ional antibiotic use for patients with acute respiratory infection in low-income and middle-income co

179 sol delivery of B. pseudomallei to establish respiratory infection in mice and studied CPS I in the c

180 different oxygen saturation targets in acute respiratory infection in older children, particularly in

181 ion for prevention of exacerbation and upper respiratory infection in patients with COPD are lacking.

182 was considered to be related to study drug (respiratory infection in the placebo group, traffic acci

183 veral virulence factors to establish chronic respiratory infections in bronchiectasis, chronic obstru

184 Many bacterial pathogens causing respiratory infections in children are common residents

185 um is occasionally used to investigate lower respiratory infections in children but has not been wide

186 pectively assessed viral etiologies of acute respiratory infections in community-based elderly indivi

187 nza virus and other respiratory pathogens to respiratory infections in community-dwelling older adult

188 Respiratory infections in early childhood are a potentia

189 Frequent viral lower respiratory infections in early life are an independent

190 fraction of PM2.5 exacerbate upper and lower respiratory infections in early life, and that the carbo

191 Breast-feeding is protective against respiratory infections in early life.

192 sis supports an inverse relationship between respiratory infections in early-life and atopic diseases

193 h human and avian viruses mounted productive respiratory infections in ferrets following ocular-only

194 viruses are one of the most common causes of respiratory infections in humans, causing 1 billion infe

195 (IAVs) are one of the most common causes of respiratory infections in humans, resulting in thousands

196 nza viruses of the H5N1 subtype cause severe respiratory infections in humans, which have resulted in

197 emerged in the spring of 2013, cause severe respiratory infections in humans.

198 s (IAVs) are among the most common causes of respiratory infections in humans.

199 yxovirus that causes deadly encephalitis and respiratory infections in humans.

200 nomic burden, being the main cause of severe respiratory infections in infants worldwide.

201 Bordetella species cause respiratory infections in mammals.

202 t has previously been shown to reduce lethal respiratory infections in mice to undetectable levels wh

203 ections in pregnant and postpartum women and respiratory infections in neonates.

204 logical studies have observed an increase in respiratory infections in subjects and populations expos

205 e was a lower incidence of exacerbations and respiratory infections in subjects treated with OC000459

206 fe and with lower rates of parental-reported respiratory infections in the consecutive periods.

207 tory evidence on the role of early childhood respiratory infections in the development of asthma and

208 ht be enormous, given the high prevalence of respiratory infections in the first year of life and the

209 Also seen in cattle, bovine PIV-3 causes respiratory infections in young calves.

210 tion to emergency department (ED) visits for respiratory infections in young children.

211 derate or severe exacerbation, but not upper respiratory infection, in patients with COPD with baseli

212 Mycoplasma pneumoniae is a leading cause of respiratory infections, including community-acquired pne

213 n for skin and soft-tissue infection (SSTI), respiratory infection, intra-abdominal infection, or uri

214 sting is essential component of severe acute respiratory infection investigation for at-risk patients

215 Respiratory infection is a common presenting feature of

216 Overall, these data demonstrate that viral respiratory infection is associated with a marked increa

217 Acute respiratory infection is the leading cause of mortality

218 The spread of many respiratory infections is determined by contact patterns

219 Rapid and definitive diagnosis of viral respiratory infections is imperative in patient triage a

220 However, zinc's therapeutic effect on respiratory infections is less clear.

221 Peninsula with a clinical syndrome of acute respiratory infections, later designated as Middle East

222 issue Infections of the Head and Neck, Upper Respiratory Infections, Lower Respiratory Tract infectio

223 Viruses are frequent causes of lower respiratory infection (LRI).

224 However, during acute viral lower respiratory infection, lung TCD8 are functionally impair

225 s between early-life exposures (infant lower respiratory infection, manual social class, home overcro

226 hogens in gastrointestinal, bloodstream, and respiratory infections may be used.

227 iddle East respiratory syndrome severe acute respiratory infection (median [quartile 1, quartile 3] 5

228 ed mouse models of Chlamydia and Haemophilus respiratory infection-mediated, ovalbumin-induced severe

229 Using a mouse respiratory infection model, we show that clinical isola

230 enza death across countries by comparing GHE respiratory infection mortality rates from countries wit

231 ears) using WHO Global Health Estimate (GHE) respiratory infection mortality rates.

232 ntly by cause of death and was strongest for respiratory infections (MRR, 0.20 [95% CI, .07-.55]).

233 iddle East respiratory syndrome severe acute respiratory infection (n = 330) admitted between Septemb

234 237,833), pneumonia (n = 52,946), and upper respiratory infections (n = 414,556).

235 iddle East respiratory syndrome severe acute respiratory infection) (n = 222).

236 They have also been isolated from a respiratory infection of chickens.

237 Respiratory infection of influenza A virus (IAV) is freq

238 atients with community-acquired severe acute respiratory infection of non-Middle East respiratory syn

239 n of MeV-specific T cells for 6 months after respiratory infection of rhesus macaques with wild type

240 During Mycobacterium tuberculosis and other respiratory infections, optimal T cell activation requir

241 a, bronchitis, bronchiolitis, a wheezy lower respiratory infection or fever and cough.

242 CI, 1%-38%; I2 = 0%; N = 1903) against acute respiratory infections or influenza-like illness.

243 Adjusted odds or hazards ratios for incident respiratory infections or non-infectious respiratory dia

244 disease-specific or other entities, such as respiratory infections or pollution, are responsible.

245 In 1990, 16 of 33 provinces had lower respiratory infections or preterm birth complications as

246 (OR = 1.013; 95% CI: 1.003, 1.023) and upper respiratory infections (OR = 1.015; 95% CI: 1.008, 1.022

247 with the following acute health conditions: respiratory infections, otitis media, gastroenteritis, n

248 ergistic interactions of smoking with infant respiratory infection (P = 0.04) and early-life home ove

249 iddle East respiratory syndrome severe acute respiratory infection patients were younger than those w

250 effect of the intervention on risk of upper respiratory infection (pinteraction=0.41).

251 the typical clinical syndrome of viral upper respiratory infection progressing to the lower respirato

252 APDS was characterized by recurrent respiratory infections, progressive airway damage, lymph

253 s were randomized if they exhibited signs of respiratory infection (purulent secretions and Clinical

254 The ability to diagnose respiratory infections rapidly and close to the patient

255 antibiotic treatment in patients with acute respiratory infections reduces antibiotic exposure and s

256 e of YLDs in 1990, 2005, and 2010, and lower respiratory infections remained the leading cause of YLL

257 ociation between household air pollution and respiratory infections, respiratory tract cancers, and c

258 e animals after intravenous infection, while respiratory infection results in virus replication in th

259 rotective effects of BCG vaccination against respiratory infection (RI) and sepsis not attributable t

260 ism from IL4 gene was significant for pooled respiratory infections (rs2070874; 1.66 [1.29-2.14]).

261 inical benefit for treatment of severe acute respiratory infections (SARIs) of viral etiology.

262 included postextubation respiratory failure, respiratory infection, sepsis and multiorgan failure, IC

263 Secondary outcomes included respiratory infection, sepsis, and multiple organ failur

264 Increased rates of malaria, respiratory infections, severe diarrhea and febrile illn

265 f pulmonary host defense mechanisms to viral respiratory infection susceptibility in very young child

266 n to communities around the world by causing respiratory infections that can be highly contagious and

267 ocalcitonin protocols in patients with acute respiratory infections thus has the potential to improve

268 Respiratory infection trends were dominated by the influ

269 Viral respiratory infections trigger severe exacerbations of a

270 Unlike other respiratory infections, tuberculosis diagnoses increase

271 patients), nausea (two patients), and upper respiratory infections (two patients).

272 = 80,399), pneumonia (n = 63,359), and upper respiratory infection (URI) (n = 359,246) among children

273 atric infections associated with viral upper respiratory infections (URIs).

274 om immunocompetent subjects during 146 upper respiratory infections (URIs); the sensitivities for rev

275 ountries with high rates of mortality due to respiratory infection using the same methods.

276 /182 prescriptions), while it was non-severe respiratory infections using the control algorithm (ALMA

277 In establishing a respiratory infection, vaccinia virus (VACV) initially r

278 Index score, chronic kidney disease, cancer, respiratory infection, vasoactive agent use, and receipt

279 Pneumonia and acute respiratory infection visits were not associated, althou

280 influenza A H7N9 virus causing severe human respiratory infections was identified in China.

281 or in vivo 25(OH)D status to increased viral respiratory infections, we poorly understand how vitamin

282 pediatric and adult civilian cases of acute respiratory infection were characterized to compile mole

283 ED visits for asthma or wheeze and for upper respiratory infections were associated with PM2.5 concen

284 ient data from trials in which patients with respiratory infections were randomly assigned to receive

285 Day care hours and number of respiratory infections were reported in follow-up questi

286 with oral amoxicillin) of suspected neonatal respiratory infections, were linked with traditional bir

287 ibuting to 14.3% of deaths), replacing lower respiratory infections, which were the leading cause of

288 Bvg(+) phase is necessary and sufficient for respiratory infection while the Bvg(-) phase is required

289 Respiratory infection with A/WSN/33 causes significant d

290 en-specific antibodies (Abs) protect against respiratory infection with influenza A virus (IAV) and S

291 esponses with desialylation may occur during respiratory infection with NA-expressing microbes and co

292 onses as well as enhanced protection against respiratory infection with P. aeruginosa compared to imm

293 ve Pneumocystis to elicit protection against respiratory infection with Pneumocystis murina.

294 Mild respiratory infection with serotype 19F pneumococci sele

295 ed significantly increased susceptibility to respiratory infection with serotype 3 S. pneumoniae rela

296 Respiratory infection with the attenuated Live Vaccine S

297 te to protection of the lung during a severe respiratory infection with vaccinia virus.

298 lmonary disease are susceptible to recurrent respiratory infections with pathogens, including nontype

299 imal models involved in vaccine research for respiratory infections, with advantages and disadvantage

300 rainfluenza viruses (HPIVs) cause widespread respiratory infections, with no vaccines or effective tr